* Alimera Sciences Inc ALIM.OQ reported a quarterly
adjusted
loss of 75 cents per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 40 cents per share.
* Revenue rose 11.9% to $13.60 million from a year ago;
analysts
expected $15.17 million.
* Alimera Sciences Inc's reported EPS for the quarter was a
loss
of 75 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Alimera Sciences Inc shares had fallen by 2.0% this
quarter and
lost 2.9% so far this year.
* The company reported a quarterly loss of $5.26 million.
* Wall Street's median 12-month price target for Alimera
Sciences
Inc is $11.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
14 at 02:30 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.40 -0.75 Missed
Jun. 30 2022 -0.55 -0.45 Beat
Mar. 31 2022 -0.69 -0.85 Missed
Dec. 31 2021 -0.42 -0.59 Missed